(Q52655284)

English

A randomized, double-blind, controlled trial of the effects of ivermectin at normal and high doses, given annually or three-monthly, against Onchocerca volvulus: ophthalmological results.

scientific article published in April 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

A randomized, double-blind, controlled trial of the effects of ivermectin at normal and high doses, given annually or three-monthly, against Onchocerca volvulus: ophthalmological results. (English)

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

0 references

Onchocerca volvulus

object named as

Onchocerca volvulus

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

3

object named as

Joseph Kamgno

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

Michel Boussinesq

8

object named as

Michel Boussinesq

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

author name string

Grace Fobi

1

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

Laurence Aimard-Favennec

4

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

Christian Lafleur

5

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

Nathalie Gardon-Wendel

6

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

Brian O L Duke

7

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

publication date

1 April 2005

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

99

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

4

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

279-289

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Variation in numbers of microfilariae of Onchocerca volvulus in the anterior chamber of the human eye

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Studies on onchocerciasis in the United Cameroon Republic. III. A four year follow-up of 6 rain-forest and 6 Sudan-savanna villages

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Community based distribution of ivermectin in eastern Sudan: acceptability and early post-treatment reactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Adverse reactions to ivermectin treatment for onchocerciasis. Results of a placebo-controlled, double-blind trial in Malawi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Adverse events following mass ivermectin therapy for onchocerciasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Effect of repeated ivermectin treatments on ocular onchocerciasis: evaluation after six to eight doses

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

The pathogenesis of chorioretinal disease in onchocerciasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Statistical analysis of correlated binary data in ophthalmology: a weighted logistic regression approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Final report of the Conference on the eradicability of Onchocerciasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Neoplastic change in Onchocerca volvulus and its relation to ivermectin treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Pathogenesis of onchocercal keratitis (River blindness).

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Blue-yellow colour vision in an onchocercal area of northern Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

The effects of multiple doses of ivermectin on ocular onchocerciasis. A six-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Ivermectin and onchocercal optic neuritis: short-term effects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Safety of and compliance with community-based ivermectin therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Side-effects of ivermectin in treatment of onchocerciasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Ocular changes with oral and transepidermal diethylcarbamazine therapy of onchocerciasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Ivermectin treatment of patients with severe ocular onchocerciasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Treatment of onchocerciasis with ivermectin (Province of Bururi, Burundi): parasitologic and clinical evaluation of different periodicities of treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

Community-based treatment with ivermectin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2004.04.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.TRSTMH.2004.04.003

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

1 reference

Europe PubMed Central

5 May 2018

http://europepmc.org/abstract/MED/15708387

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52655284&oldid=1864578361"